Clinical and Pharmacokinetic Trial of Intra-Abdominal Irinotecan

NCT00183859 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Adenocarcinoma
Gastric Cancer

Interventions

DRUG: irinotecan

Sponsor

University of Southern California